{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpoliticos-pulse-check.simplecast.com%2Fepisodes%2Fhow-svbs-failure-affects-health-tech-b5_dipAK","width":444,"version":"1.0","type":"rich","title":"How SVB's failure affects health tech","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/4da913b0-f9d2-4c36-aafd-0cefba14ffbc/53dd2434-9a18-4ec1-b716-3a0d79d20428/politico-pulse-check-audio-audio.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/64c5a915-c8a5-4e84-a8a0-139d6f5e02e7\" height=\"200\" width=\"100%\" title=\"How SVB&apos;s failure affects health tech\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Silicon Valley Bank had many health care and biotech startups among its client base. Now, the bank’s failure last Friday is raising questions about how much this could hurt emerging health companies. Host Ruth Reader talks with Michael Yang, a managing partner with OMERS Ventures, a global early-stage technology venture firm, to get the industry’s read."}